The Centers for Medicare & Medicaid Services has selected 61 applicants for the Value in Opioid Use Disorder Treatment Demonstration, a four-year Medicare payment model beginning this month for selected health care providers who agree to participate.

Participants will test whether a new care management fee and performance-based incentive payment for OUD treatment services reduces hospitalizations and improves health outcomes for Medicare fee-for-service patients with OUDs, including those dually eligible for Medicaid. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorizes $10 million annually in fiscal years 2021-2024 to pay for the treatment services. 

Related News Articles

Blog
A recent report from the Lown Institute that ranks hospitals on what they deem to be unnecessary hospital services, tests and procedures attempts to make…
Headline
Effective immediately, Medicare will pay $750 to administer monoclonal antibodies to COVID-19 patients in their residence or temporary lodging and increase…
Headline
Eleven organizations representing physicians and hospitals, including the AHA, today urged Health and Human Services Secretary Xavier Becerra to reconsider…
Headline
The AHA today urged the Centers for Medicare & Medicaid Services to apply its recently increased Medicare payment rates for COVID-19 vaccine…
Headline
The Centers for Medicare & Medicaid Services April 29 issued a rule finalizing changes to the Comprehensive Care for Joint Replacement model, which bundles…
News
The Centers for Medicare & Medicaid Services late today issued a proposed rule that would increase Medicare inpatient prospective payment system rates…